Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPLETE T1D Trial
2006-006375-21Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin lispro protamine, insulin detemir and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change in hemoglobin A1c from baseline to 32 weeks. Started Feb 2007; status: completed.
02
Drugs
insulin lispro protamineinsulin detemirhuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-006375-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006375-21.